Online citations, reference lists, and bibliographies.

Surgical Resection Of Mesothelioma: An Evidence-free Practice

Y C Gary Lee
Published 2014 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
This paper references
10.1136/oem.17.4.260
Diffuse Pleural Mesothelioma and Asbestos Exposure in the North Western Cape Province
J. Wagner (1960)
10.1200/JCO.2003.11.136
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.
N. Vogelzang (2003)
10.1097/00063198-200007000-00003
Management of malignant pleural mesothelioma: a critical review
Y. Lee (2000)
10.1016/S0022-5223(99)70469-1
Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.
D. Sugarbaker (1999)
10.1056/NEJMOA030287
A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema.
A. Fishman (2003)
10.1136/thoraxjnl-2013-203846
Surgery in the treatment of malignant pleural mesothelioma: recruitment into trials should be the default position
A. Datta (2013)
10.1200/JCO.20005.14.589
Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada.
J. Van Meerbeeck (2005)
10.1016/S1470-2045(11)70149-8
Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study
T. Treasure (2011)
10.1111/j.1440-1843.2011.01975.x
Asbestos use and asbestos-related diseases in Asia: past, present and future.
G. Le (2011)
10.1007/S002680020021
Treatment of Malignant Mesothelioma
M. Jaklitsch (2001)
10.2471/BLT.11.086678
Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008.
V. Delgermaa (2011)
10.1016/S0140-6736(14)60418-9
Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial
R. Rintoul (2014)
10.1378/chest.11-3204
Postmortem findings of malignant pleural mesothelioma: a two-center study of 318 patients.
Rhian S Finn (2012)



This paper is referenced by
10.1016/j.jtho.2018.10.005
Prediction modelling using routine clinical parameters to stratify survival in Malignant Pleural Mesothelioma patients undergoing cytoreductive surgery
Edward J A Harris (2019)
10.21037/ATM.2020.03.58
Malignant pleural mesothelioma: between pragmatism and hope.
M. Migliore (2020)
10.1053/j.semtcvs.2015.02.007
Surgical Management of Malignant Pleural Mesothelioma: An Update of Clinical Evidence.
Christopher Q Cao (2015)
10.2147/OTT.S134126
Isolated thoracic perfusion with chemofiltration for progressive malignant pleural mesothelioma
K. Aigner (2017)
10.1016/j.jtcvs.2014.09.073
Doubt about effectiveness of lung metastasectomy for sarcoma.
Tom Treasure (2015)
10.1016/j.ijrobp.2016.08.020
Remember Pleurodesis!
Tom Treasure (2017)
10.2217/fon.14.256
Cytoreductive surgery and hyperthermic intrapleural chemotherapy for malignant pleural diseases: preliminary experience.
M. Migliore (2015)
10.1097/SLA.0000000000001266
Extrapleural Pneumonectomy Is Not Shown to Be Clinically Effective in the Treatment of Malignant Pleural Mesothelioma.
Giuseppe Cardillo (2017)
10.1016/j.freeradbiomed.2018.10.401
Iron addiction with ferroptosis‐resistance in asbestos‐induced mesothelial carcinogenesis: Toward the era of mesothelioma prevention
S. Toyokuni (2019)
10.2217/fon.14.207
Finding the evidence for pulmonary metastasectomy in colorectal cancer: the PulMicc trial.
M. Migliore (2015)
10.1007/s13665-016-0133-0
Nutrition, exercise, and complementary medicine: potential role in mesothelioma?
Sanjeevan Muruganandan (2016)
10.1080/17476348.2018.1398085
Surgical and non-surgical management of malignant pleural effusions
Deirdre B Fitzgerald (2018)
10.2217/fon.15.274
The MesoVATS trial: is there a future for video-assisted thoracoscopic surgery partial pleurectomy?
Robert C Rintoul (2015)
10.2217/fon.15.259
The Second Mediterranean Symposium: considering mesothelioma from a local and international perspective.
Tom Treasure (2015)
A randomised controlled trial of regular early specialist palliative care on quality of life in malignant pleural mesothelioma – ‘RESPECT-Meso’
F. Brims (2018)
10.1007/s12055-017-0606-y
Surgery for mesothelioma: the evidence base and a pragmatic approach to surgical treatment
Vasudev Baburaya Pai (2017)
10.1016/j.jtho.2015.12.108
A Novel Clinical Prediction Model for Prognosis in Malignant Pleural Mesothelioma Using Decision Tree Analysis
F. Brims (2016)
10.1016/j.cllc.2018.08.007
Survival by Histologic Subtype of Malignant Pleural Mesothelioma and the Impact of Surgical Resection on Overall Survival
V. Verma (2018)
10.1016/j.jtcvs.2014.10.083
Fifteen years in the evaluation of extrapleural pneumonectomy: Lessons to be learned.
T. Treasure (2015)
10.1136/thoraxjnl-2018-212380
Early specialist palliative care on quality of life for malignant pleural mesothelioma: a randomised controlled trial
F. Brims (2019)
Semantic Scholar Logo Some data provided by SemanticScholar